Transketolase (TKT) is a ubiquitous enzyme used in multiple metabolic pathways. We show here by gene targeting that TKT-null mouse embryos are not viable and that disruption of one TKT allele can cause growth retardation (Ϸ35%) and preferential reduction of adipose tissue (Ϸ77%). Other TKT ؉/؊ tissues had moderate (Ϸ33%; liver, gonads) or relatively little (Ϸ7 to 18%; eye, kidney, heart, brain) reductions in mass. These mice expressed a normal level of growth hormone and reduced leptin levels. No phenotype was observed in the TKT ؉/؊ cornea, where TKT is especially abundant in wild-type mice. The small female TKT ؉/؊ mice mated infrequently and had few progeny (with a male/female ratio of 1.4:1) when pregnant. Thus, TKT in normal mice appears to be carefully balanced at a threshold level for well-being. Our data suggest that TKT deficiency may have clinical significance in humans and raise the possibility that obesity may be treated by partial inhibition of TKT in adipose tissue.Transketolase (EC 2.2.1.1) (TKT) is a thiamine diphosphate-dependent enzyme linking the nonoxidative branch of the pentose phosphate pathway (PPP) to the glycolytic pathway. The PPP generates sugar phosphates for intermediary biosynthesis and nucleic acid synthesis and NADPH for reductive biosynthesis (26,31). Fatty acid biosynthesis and steroid biosynthesis utilize large amounts of NADPH. TKT is expressed in most tissues throughout the animal and plant kingdoms (27). It is prevalent in proliferating tumor cells, and its repression can inhibit tumor cell growth (2).Our interest in TKT was stimulated by its abundance in the cornea of mice (25) and rabbits (9). In mice, TKT comprises approximately 10% (25) and aldehyde dehydrogenase class 3 (ALDH3) comprises approximately 40% (4, 16) of the watersoluble protein of the corneal epithelial cells. By analogy with the use of enzymes as lens crystallins, we have speculated that the abundant metabolic enzymes in the cornea may serve a structural as well as metabolic role (4,21,22).In the present investigation we disrupted the TKT gene by homologous recombination to test whether corneal clarity is dependent on the concentration of this enzyme. We were only able to obtain viable TKT ϩ/Ϫ mice. While their corneas appeared normal, the TKT haploinsufficient mice were often smaller and the small females were relatively infertile. The sizes of the organs were differentially affected, with adipose tissue being markedly reduced in the TKT ϩ/Ϫ mice. It thus appears that in mice, as found earlier in plants (8), a reduction in TKT leads to multiple phenotypes and metabolic disturbances. Moreover, our results suggest that TKT haploinsufficiency or a reduction in TKT activity may have clinical implications in humans.
MATERIALS AND METHODS
Generation and mating of TKT؉/؊ mice. A 12.5-kb genomic clone containing the mouse TKT gene was isolated from a 129Sv library (Stratagene, La Jolla, Calif.). The targeting construct was created by replacing a 2.8-kb BamHI-BamHI fragment (24) with a 1.6-kb PGK/neo cassette for...